Falling through the cracks: Missed opportunities for diagnosing and treating lupus in schizophrenia

Schizophr Res. 2021 Dec:238:185-187. doi: 10.1016/j.schres.2021.10.013. Epub 2021 Nov 3.

Authors

Matthew C Johnson¹, Matthew L Baum², Paulo Lizano³

Affiliations

¹ Beth Israel Deaconess Medical Center, Psychiatry, Boston, MA, United States of America.
² Brigham and Women's Hospital, Psychiatry, Boston, MA, United States of America.
³ Beth Israel Deaconess Medical Center, Psychiatry, Boston, MA, United States of America; Department of Psychiatry, Harvard Medical School, Boston, MA, United States of America. Electronic address: plizano@bidmc.harvard.edu.

PMID: 34742126
DOI: 10.1016/j.schres.2021.10.013

No abstract available

Keywords: Clozapine; Inflammation; Lupus; SLE; Schizophrenia.

MeSH terms

Antipsychotic Agents* / therapeutic use
Clozapine* / therapeutic use
Humans
Schizophrenia* / drug therapy
Schizophrenia* / therapy

Substances

Antipsychotic Agents
Clozapine